rs121913517
|
|
melanoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
A meta-analysis of somatic mutations from next generation sequencing of 241 melanomas: a road map for the study of genes with potential clinical relevance.
|
24755198 |
2014 |
rs121913517
|
|
melanoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412.
|
15790786 |
2005 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Activation mutations of human c-KIT resistant to imatinib mesylate are sensitive to the tyrosine kinase inhibitor PKC412.
|
15790786 |
2005 |
rs121913517
|
|
melanoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Somatic activation of KIT in distinct subtypes of melanoma.
|
16908931 |
2006 |
rs121913517
|
|
melanoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
|
17372901 |
2007 |
rs121913517
|
|
melanoma
|
G |
0.700 |
CausalMutation
|
CLINVAR |
Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
|
24661573 |
2014 |
rs121913517
|
|
melanoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.
|
9438854 |
1998 |
rs121913517
|
|
melanoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogene.
|
19812602 |
2010 |
rs121913517
|
|
melanoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
KIT gene mutations and copy number in melanoma subtypes.
|
18980976 |
2008 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours.
|
11276010 |
2001 |
rs121913517
|
|
melanoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours.
|
11276010 |
2001 |
rs121913517
|
|
melanoma
|
G |
0.700 |
CausalMutation
|
CLINVAR |
The GIST of targeted therapy for malignant melanoma.
|
24531699 |
2014 |
rs121913517
|
|
melanoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors.
|
9438854 |
1998 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Response to imatinib mesylate depends on the presence of the V559A-mutated KIT oncogene.
|
19812602 |
2010 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases.
|
16046538 |
2005 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
KIT gene mutations and copy number in melanoma subtypes.
|
18980976 |
2008 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
KIT as a therapeutic target in metastatic melanoma.
|
21642685 |
2011 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition.
|
17372901 |
2007 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Activity of dasatinib against L576P KIT mutant melanoma: molecular, cellular, and clinical correlates.
|
19671763 |
2009 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Complete response of stage IV anal mucosal melanoma expressing KIT Val560Asp to the multikinase inhibitor sorafenib.
|
18936790 |
2008 |
rs121913517
|
|
melanoma
|
C |
0.700 |
GeneticVariation
|
CLINVAR |
Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.
|
7530509 |
1995 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification.
|
21690468 |
2011 |
rs121913517
|
|
melanoma
|
A |
0.700 |
CausalMutation
|
CLINVAR |
Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines.
|
7530509 |
1995 |